tHEORetically Speaking
Menu Close
  • Home
  • Guest Authors
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

Panalgo

0

Preparing a Successful ICER Strategy: Lessons from the Frontlines

Posted on October 29, 2021 by tHEORetically Speaking

Consequential prescription drug pricing decisions in the United States increasingly involve high-stakes interactions between the manufacturer and the Institute for Clinical and Economic Review (ICER). Continue Reading →

ICER, Panalgo, Pharmaceutical Pricing drug pricing, ICER, Panalgo

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • Global Planning to Local Execution Market Success
  • Between Two Scientists: Data Linkage – Like Making a Fine, Blended Wine from Varietal Data Sources
  • The Sooner, the Better: Detecting and Decoding Alzheimer’s with Real-World Data
  • Ongoing Medicare Privatization Will Hurt Pharma As Much As the IRA

HealthEconomics.Com Twitter Feed

www_healthecon Follow

@ ·
now

Reply on Twitter Retweet on Twitter Like on Twitter Twitter
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2023 tHEORetically Speaking. All rights reserved.
Hiero by aThemes